Clinical Trial Update: Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial update evaluating a combination of pemetrexed and oxaliplatin in patients with metastatic solid tumors or lymphoma; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumors

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• Pemetrexed (pemetrexed)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Lymphoma, Solid Tumor | Phase 1 | Status: COMPLETED